References
Müllegger RR, Glatz M. Skin manifestations of Lyme borreliosis: diagnosis and management. Am J Clin Dermatol 2008; 9(6): 355–68
Binder B, Kerl H, Müllegger RR. Differential diagnosis of acrodermatitis chronica atrophicans with emphasis on chronic venous insufficiency. Phlebologie 2004; 33: 191–8
Stanek G, Strie F. Lyme borreliosis. Lancet 2003; 362(9396): 1639–47
Asbrink E, Hovmark A, Olsson I. Clinical manifestations of acrodermatitis chronica atrophicans in 50 Swedish patients. Zentralbl Bakteriol Mikrobiol Hyg A 1986; 263(1–2): 253–61
Wormser GP, Dattwyler RJ, Shapiro ED, et al. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2006; 43(9): 1089–134
Klempner MS, Hu LT, Evans J, et al. Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. N Engl J Med 2001; 345(2): 85–92
Maraspin V, Cimperman J, Lotric-Furlan S, et al. Solitary borrelial lymphocytoma in adult patients. Wien Klin Wochenschr 2002; 114(13–14): 515–23
Aberer E, Breier F, Stanek G, et al. Success and failure in the treatment of acrodermatitis chronica atrophicans. Infection 1996; 24(1): 85–7
Åsbrink E. Acrodermatitis chronica atrophicans. Clin Dermatol 1993; 11(3): 369–75
Rights and permissions
About this article
Cite this article
Treatment with antibacterials gets the ‘tick’ when treating skin manifestations of Lyme disease. Drugs Ther. Perspect 25, 17–19 (2009). https://doi.org/10.2165/0042310-200925070-00005
Published:
Issue Date:
DOI: https://doi.org/10.2165/0042310-200925070-00005